Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu
Trial record 3 of 14 for:    monalizumab

Study of a Humanized Antibody Initiated 2 Months After an HLA Matched Allogenic Stem Cell Transplantation (PIRAT)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT02921685
Recruitment Status : Unknown
Verified September 2018 by Institut Paoli-Calmettes.
Recruitment status was:  Recruiting
First Posted : October 3, 2016
Last Update Posted : September 19, 2018
Sponsor:
Collaborator:
Innate Pharma
Information provided by (Responsible Party):
Institut Paoli-Calmettes

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Unknown
Estimated Primary Completion Date : May 28, 2019
Estimated Study Completion Date : April 28, 2020